A hospital in Wuhan says it has conducted autopsies on two patients who died from coronavirus infections. Jinyintan Hospital says Sunday's results have been sent for further examination. Researchers will study the pathology of COVID-19 to better treat patients in critical condition. Separately, China has approved the sale of the first potential drug to treat the infection, Favipiravir, after good clinical trials. A pharmaceutical company in Zhejiang Province has begun manufacturing the drug, and the company says clinical testing will continue. Favipiravir is an existing drug which is widely used to treat flu symptoms.

Advertisement
Code: SPORTS20. Sports Travel Discount. Get $20 Off. Promo Code: SPORTS20

More videos

RT 01 Apr 2020 21:00 CEST

Not safe at home

Newsy 01 Apr 2020 20:33 CEST

Federal prisons isolating inmates